AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 33(4), 1984, pp. 684-689
Copyright © 1984 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eckels, K. H.
Right arrow Articles by Halstead, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eckels, K. H.
Right arrow Articles by Halstead, S. B.

Selection of Attenuated Dengue 4 Viruses by Serial Passage in Primary Kidney Cells

V. Human Response to Immunization with a Candidate Vaccine Prepared in Fetal Rhesus Lung Cells

K. H. Eckels*, R. McN. Scott*, W. H. Bancroft*, J. Brown{dagger}, D. R. Dubois*, P. L. Summers*, P. K. Russell* AND S. B. Halstead{ddagger}
* Walter Reed Army Institute of Research, Washington, D.C. 20307
{dagger} United States Army Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21701
{ddagger} Department of Tropical Medicine and Medical Microbiology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii 96816

A dengue 4 (strain H241, PDK35-TD3 FRhL p3) vaccine attenuated by passage in primary dog kidney cells followed by passage and final vaccine preparation in DBS-FRhL-2 cells was tested in five yellow fever-immune volunteers. Only two volunteers seroconverted by producing hemagglutination-inhibiting and neutralizing antibodies. Mild illness, compatible with dengue infection was found only in the individuals who later developed antibodies. Both volunteers developed a rash by the 8th day following vaccination, coinciding with a slight elevation in temperature and leukopenia. Additionally, several serum enzymes were elevated during the observation period. Dengue 4 virus was isolated from the blood of the two infected volunteers starting as early as day 5 post vaccination. During the viremic period, which lasted 5 days, phenotypically-changed virus was recovered, indicating genetic instability of the vaccine virus. The clinical disease and immune response in the two infected individuals was probably related to replication of the variant virus. Further testing of this vaccine in its present form is not indicated.

Accepted for publication August 1, 1983.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
A. T. Ciota, A. O. Lovelace, S. A. Jones, A. Payne, and L. D. Kramer
Adaptation of two flaviviruses results in differences in genetic heterogeneity and virus adaptability
J. Gen. Virol., September 1, 2007; 88(9): 2398 - 2406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Society of Tropical Medicine and Hygiene.